Study: J&J's stent better than Boston Scientific's

09/13/2007 | NYTimes.com

Patients who received Johnson & Johnson's Cypher drug-coated stent were less likely to suffer heart attacks than patients who received Boston Scientific Corp.'s Taxus stent and bare-metal stents, a study revealed. Researchers also found that Taxus stents slightly increased the risk of fatal clots in patients compared with Cypher and bare-metal stents.

View Full Article in:

NYTimes.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR
Director of Operations - GBS
Mayo Clinic
Rochester, MN